Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia M Klimek

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Blood|December 14, 2011
It dices, it splices!Virginia M Klimek
Current Opinion in Hematology|January 25, 2013
Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemiaVirginia M Klimek
Current Opinion in Hematology|January 19, 2016
Therapy-related myeloid neoplasms: what's in a name?Virginia M Klimek, Nancy J Tray
Leukemia & Lymphoma|October 9, 2010
Hypomethylating agents in acute lymphoblastic leukemia: untapped potential?Virginia M Klimek, Martin S Tallman
Cytokines, Cellular & Molecular Therapy|February 28, 2003
Serum levels of melanoma-inhibiting activity do not predict relapse in melanoma patientsVirginia M Klimek, Linda Williams, Paul B Chapman
Leukemia Research|December 14, 2011
Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemiaVirginia M Klimek, Emily K Dolezal, Larry Smith, et al.
Leukemia Research|June 1, 2019
Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancerZachary D Epstein-Peterson, Sean M Devlin, Eytan M Stein, et al.
Leukemia Research|May 22, 2012
Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromesVirginia M Klimek, Emily K Dolezal, Michael T Tees, et al.
BMJ Supportive & Palliative Care|April 27, 2021
Palliative Medicine in Myelodysplastic Syndromes: Patients and Caregivers - A Qualitative StudyAnjali V Desai, Virginia M Klimek, Peter J Wan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromesVirginia M Klimek, Sophia Fircanis, Peter Maslak, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Blood|December 14, 2011
It dices, it splices!Virginia M Klimek
Current Opinion in Hematology|January 25, 2013
Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemiaVirginia M Klimek
Current Opinion in Hematology|January 19, 2016
Therapy-related myeloid neoplasms: what's in a name?Virginia M Klimek, Nancy J Tray
Leukemia & Lymphoma|October 9, 2010
Hypomethylating agents in acute lymphoblastic leukemia: untapped potential?Virginia M Klimek, Martin S Tallman
Cytokines, Cellular & Molecular Therapy|February 28, 2003
Serum levels of melanoma-inhibiting activity do not predict relapse in melanoma patientsVirginia M Klimek, Linda Williams, Paul B Chapman
Leukemia Research|December 14, 2011
Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemiaVirginia M Klimek, Emily K Dolezal, Larry Smith, et al.
Leukemia Research|June 1, 2019
Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancerZachary D Epstein-Peterson, Sean M Devlin, Eytan M Stein, et al.
Leukemia Research|May 22, 2012
Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromesVirginia M Klimek, Emily K Dolezal, Michael T Tees, et al.
BMJ Supportive & Palliative Care|April 27, 2021
Palliative Medicine in Myelodysplastic Syndromes: Patients and Caregivers - A Qualitative StudyAnjali V Desai, Virginia M Klimek, Peter J Wan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromesVirginia M Klimek, Sophia Fircanis, Peter Maslak, et al.
Pageof 5